We discuss how the legacy of racism in American healthcare continues to affect today’s research, and share strategies for programs to communicate with underrepresented and marginalized populations.
Find the CANCER BUZZ podcast on Apple Podcasts, Spotify, or wherever you get your podcasts!
From unethical experimentation to systematic exclusion, racism has played a terrible role in the development of American healthcare. On this mini-podcast, we discuss how the legacy of clinical trials continues to affect today’s research, and share strategies for cancer programs to effectively communicate with underrepresented and marginalized populations.
Guest: Christopher Lathan, MD, MS, MPH, Medical Director, Dana-Farber Cancer Institute at St. Elizabeth's Medical Center; Associate Medical Director, DFCI Network
Related Content:
The views and opinions expressed herein are those of the author(s)/faculty member(s) and do not reflect the official policy or position of their employer(s) or the Association of Cancer Care Centers.
July 8, 2026
June 30, 2026
At the 2026 ASCO Annual Meeting, the Louisiana Oncology Society received the ASCO Jeffrey C Ward Affiliate Advocacy Award for advancing critical advocacy priorities that have translated into meaningful legislative victories. The Iowa Oncology Society and Washington State Medical Oncology Society were also recognized for their advocacy efforts in 2025 at the meeting, receiving second place awards.
